Tuesday - December 24, 2024

Chronic Nightly Dosing of Lasmiditan for Migraine Prevention

2024-11-12

ALEXANDRIA, Virginia, Nov. 12 -- ELI LILLY AND COMPANY, Indianapolis, Indiana has been assigned a patent (No. US 12138254 B2, initially filed Sept. 3, 2019) developed by three inventors Robert Russell Conley, Annapolis, Maryland; Gudarz Davar, Indianapolis, Indiana; and Kirk Willis Johnson, Carmel, Indiana, for "Chronic nightly dosing of lasmiditan for migraine prevention." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Chronic Nightly Dosing of Lasmiditan for Migraine Prevention

Information Request Form

Copyright Targeted News Service 2024